Saccharomyces boulardii induced sepsis: successful therapy with voriconazole after treatment failure with fluconazole

Clicks: 205
ID: 265682
2005
Free PDF
Article Quality & Performance Metrics
Overall Quality Improving Quality
0.0 /100
Combines engagement data with AI-assessed academic quality
AI Quality Assessment
Not analyzed
Abstract
Saccharomyces boulardii is frequently used for prevention and treatment of all forms of diarrhoea. We report the case of a 19-y-old white male with an underlying severe neurological disease, who developed a fungal sepsis after prophylactic application of a drug containing S. boulardii. Initial treat …
Reference Key
o2005scandinaviansaccharomyces Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Burkhardt O;Köhnlein T;Pletz M;Welte T;;
Journal scandinavian journal of infectious diseases
Year 2005
DOI
DOI not found
URL
http://www.ncbi.nlm.nih.gov/pubmed/15764194
Keywords
National Center for Biotechnology Information NCBI NLM MEDLINE review humans pubmed abstract nih national institutes of health national library of medicine treatment outcome adult female male case reports aged middle aged Child Infant sepsis / drug therapy* sepsis / microbiology voriconazole antifungal agents / therapeutic use* pyrimidines / therapeutic use* triazoles / therapeutic use* pmid:15764194 doi:10.1080/00365540510026454 olaf burkhardt thomas köhnlein tobias welte fluconazole / therapeutic use* saccharomyces / pathogenicity* sepsis / physiopathology

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.